Estia Health (EHE.AX) Stock Price

Estia Health Price

Delisted·Dec 17, 2023
3.08AUD
Last traded price

Revenue has compounded at 30.9% per year over the past 9 years to 754.30 M AUD. Earnings per share have declined at 30.8% per year over the last 5 years. Estia Health's net margin stands at -4.5%, down from 7.0% several years earlier. Estia Health currently offers a dividend yield of about 7.28%. The dividend has grown at 1.8% per year over the past 8 years.

Estia Health stock price

Volume
Ex-Dividend
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Estia Health over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Estia Health stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Estia Health's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Estia Health Stock Price History
DateEstia Health Price
Access this data via the Eulerpool API

Estia Health Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
636.91 M AUD
87.46 M AUD
-116.91 M AUD
Jan 1, 2021
646.31 M AUD
52.18 M AUD
6.00 M AUD
Jan 1, 2022
671.07 M AUD
-36.11 M AUD
-52.36 M AUD
Jan 1, 2023
754.30 M AUD
-23.99 M AUD
-33.90 M AUD
Jan 1, 2024 (e)
876.98 M AUD
41.71 M AUD
37.86 M AUD
Jan 1, 2025 (e)
943.46 M AUD
66.70 M AUD
43.08 M AUD
Jan 1, 2026 (e)
988.12 M AUD
74.38 M AUD
49.49 M AUD
Jan 1, 2027 (e)
941.19 M AUD
82.40 M AUD
53.32 M AUD

Estia Health Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 25, 2026, 1:10 PM
 
REVENUEM AUD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM AUD
EBITM AUD
EBIT MARGIN%
NET INCOMEM AUD
NET INCOME GROWTH%
DIV.AUD
DIV. GROWTH%
SHARESM
201320142015201620172018201920202021202220232024e2025e2026e2027e
66.00284.00442.00524.00546.00585.00636.00646.00671.00754.00876.00943.00988.00941.00
330.3055.6318.554.207.148.721.573.8712.3716.187.654.77-4.76
90.9191.5590.0589.8990.6690.9491.9889.9490.3191.1191.1191.1191.1191.11
687.0060.00260.00398.00471.00495.00532.00585.00581.00606.00687.00798.16859.21900.21857.38
8.0054.0074.0068.0064.0065.0087.0052.00-36.00-23.0041.0066.0074.0082.00
12.1219.0116.7412.9811.7211.1113.688.05-5.37-3.054.687.007.498.71
-14.00-22.0027.0040.0041.0041.00-116.005.00-52.00-33.0037.0043.0049.0053.00
57.14-222.7348.152.50-382.93-104.31-1,140.00-36.54-212.1216.2213.958.16
0.190.030.110.340.340.34
209.09
190.30190.30146.14193.45225.72261.37261.87261.01264.31260.52258.16258.16258.16258.16258.16
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Estia Health generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Estia Health retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Estia Health's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Estia Health has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Estia Health's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Estia Health stock margins

The Estia Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Estia Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Estia Health.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
90.90 %
11.13 %
7.05 %
Jan 1, 2020
91.93 %
13.73 %
-18.36 %
Jan 1, 2021
90.02 %
8.07 %
0.93 %
Jan 1, 2022
90.43 %
-5.38 %
-7.80 %
Jan 1, 2023
91.19 %
-3.18 %
-4.49 %
Jan 1, 2024 (e)
91.19 %
4.76 %
4.32 %
Jan 1, 2025 (e)
91.19 %
7.07 %
4.57 %
Jan 1, 2026 (e)
91.19 %
7.53 %
5.01 %

Estia Health Stock Revenue, EBIT, Earnings per Share

The Estia Health earnings per share therefore indicates how much revenue Estia Health has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2019
2.24 AUD
0.25 AUD
0.16 AUD
Jan 1, 2020
2.44 AUD
0.34 AUD
-0.45 AUD
Jan 1, 2021
2.45 AUD
0.20 AUD
0.02 AUD
Jan 1, 2022
2.58 AUD
-0.14 AUD
-0.20 AUD
Jan 1, 2023
2.92 AUD
-0.09 AUD
-0.13 AUD
Jan 1, 2024 (e)
3.40 AUD
0.16 AUD
0.15 AUD
Jan 1, 2025 (e)
3.65 AUD
0.26 AUD
0.17 AUD
Jan 1, 2026 (e)
3.83 AUD
0.29 AUD
0.19 AUD

Estia Health business model & stock analysis

Estia Health Ltd is a publicly traded company in Australia that specializes in providing aged care services. The company was founded in 2010 and has its headquarters in Melbourne. Estia Health's business model involves providing care services for elderly individuals who require assistance due to age, illness, or injury. The company offers a wide range of services, including nursing beds, respite care, physiotherapy, occupational therapy, and specialized care. Estia Health currently operates over 70 aged care facilities in Australia, with a total of over 7,000 nursing beds. The company employs over 8,000 staff members and has an annual revenue of over 660 million Australian dollars. One of the main pillars of Estia Health's business model is the provision of high-quality care services. The company places great emphasis on the education and training of its staff to ensure they have the skills and knowledge to professionally and empathetically care for elderly individuals. Another feature of Estia Health's business model is the diversification of the services offered. The company provides both long-term and short-term care and rehabilitation services to meet the varying needs of its clients. Estia Health operates in three different sectors: Residential Care, In-Home Care, and Health Care. Residential Care refers to long-term care in a nursing home. Here, Estia Health offers services such as care provided by qualified nursing staff, medical care, physiotherapy and occupational therapy treatments, as well as leisure activities and entertainment programs. In-Home Care is a service that allows elderly individuals and individuals with disabilities to stay in their own homes while still receiving the necessary care and support. Estia Health offers services such as care provided by qualified nursing staff, assistance with personal care, food preparation, household cleaning, physiotherapy and occupational therapy treatments, as well as transportation services. Health Care encompasses a wide range of health services for elderly individuals, including palliative care, rehabilitation, and specialized care for individuals with Alzheimer's or other dementia-related illnesses. The company provides qualified nursing staff who are specifically trained to treat patients with complex health issues. In addition to the mentioned services, Estia Health also offers a range of products and equipment for the care and support of elderly individuals. These include items such as wheelchairs, electric beds, bath lifts, and other daily living aids. Overall, Estia Health is a company that specializes in providing high-quality care services for elderly individuals. The company's business model is based on the diversification of services offered and the provision of high-quality and empathetic care and support services to clients with varying needs and requirements.

Estia Health SWOT Analysis

Strengths

Estia Health Ltd possesses several strengths that contribute positively to its position in the market. Firstly, the company has a strong presence and reputation in the aged care industry. This is reflected in its extensive network of high-quality residential aged care facilities across Australia.

Secondly, Estia Health Ltd has a skilled and dedicated workforce. The company invests in recruiting and training competent healthcare professionals who provide personalized care to residents. This emphasis on human resources enables Estia Health Ltd to deliver exceptional services to its clientele.

Lastly, strategic partnerships and collaborations with leading healthcare organizations grant Estia Health Ltd access to advanced technologies and medical expertise, enhancing the company's ability to offer innovative and comprehensive care solutions.

Weaknesses

Despite its strengths, Estia Health Ltd also faces certain weaknesses that should be taken into account. One major weakness is the company's susceptibility to changes in government regulations and policies regarding aged care funding. Adverse modifications could potentially impact Estia Health Ltd's financial performance and operations.

Another weakness lies in the company's reliance on third-party service providers for certain ancillary services. This dependency creates a risk of inconsistencies in service quality and potential disruptions in the delivery of those services, which could affect overall customer satisfaction.

Opportunities

Several opportunities exist for Estia Health Ltd in the aged care market. Firstly, the aging population in Australia presents a considerable growth opportunity, as the demand for aged care services is expected to increase in the coming years. Estia Health Ltd can position itself to meet this demand through facility expansions and service enhancements.

Additionally, technological advancements offer opportunities for Estia Health Ltd to improve operational efficiency and enhance the care experience for residents. Implementation of telehealth solutions, remote monitoring, and electronic health record systems can streamline processes and enable better communication among healthcare providers, residents, and their families.

Estia Health Ltd can also explore partnerships with insurance providers to offer comprehensive healthcare packages that encompass both residential and home care services. This approach can cater to a broader range of customer needs and preferences while diversifying the company's revenue streams.

Threats

Estia Health Ltd faces certain threats that could pose challenges to its growth and profitability. Firstly, intense competition within the aged care industry means that Estia Health Ltd must consistently differentiate itself and maintain high service standards in order to retain and attract clients.

Another significant threat is the potential for reputational damage due to instances of substandard care or misconduct. Negative publicity can lead to a loss of trust and credibility, impacting Estia Health Ltd's customer base and overall brand image.

Lastly, economic downturns and changes in government funding policies can exert financial pressure on Estia Health Ltd. This may affect its ability to invest in facility upgrades, staff training, and technology adoption, limiting its competitiveness in the market.

Estia Health Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Estia Health historical P/E ratio, EBIT multiple, and P/S ratio

Estia Health annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Estia Health shares outstanding

The number of shares of Estia Health was 258.16 M in 2025. This indicates how many shares Estia Health is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2019
261.87 M Stocks
Jan 1, 2020
261.01 M Stocks
Jan 1, 2021
264.31 M Stocks
Jan 1, 2022
260.52 M Stocks
Jan 1, 2023
258.16 M Stocks
Jan 1, 2024 (e)
258.16 M Stocks
Jan 1, 2025 (e)
258.16 M Stocks
Jan 1, 2026 (e)
258.16 M Stocks

Estia Health Dividend History

9 years of dividend payments · 2 consecutive increases

YearAnnual DividendYoY ChangePayments
20230.22AUD 568.1%
20220.03AUD 2.2%
20210.03AUD 57.4%
20200.08AUD 65.8%
20190.23AUD 0.0%
20180.23AUD 97.5%
20170.11AUD 68.7%
20160.37AUD 88.2%
20150.19AUD

Estia Health dividend history and estimates

In 2025, Estia Health paid a dividend amounting to 0.34 AUD. Dividend means that Estia Health distributes a portion of its profits to its owners.
  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2019 (e)
0.23 AUD
0.00 AUD
Jan 1, 2020 (e)
0.08 AUD
0.00 AUD
Jan 1, 2021 (e)
0.00 AUD
0.03 AUD
Jan 1, 2022 (e)
0.03 AUD
0.00 AUD
Jan 1, 2023 (e)
0.22 AUD
-0.12 AUD
Jan 1, 2024 (e)
0.17 AUD
0.17 AUD
Jan 1, 2025 (e)
0.00 AUD
0.34 AUD
Jan 1, 2026 (e)
0.00 AUD
0.34 AUD

Estia Health dividend payout ratio

In 2025, Estia Health had a payout ratio of 205.49%. The payout ratio indicates the percentage of the company's profits that Estia Health distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2019
143.13 %
Jan 1, 2020
-17.22 %
Jan 1, 2021
144.75 %
Jan 1, 2022
-16.70 %
Jan 1, 2023
-170.82 %
Jan 1, 2024 (e)
233.79 %
Jan 1, 2025 (e)
205.49 %
Jan 1, 2026 (e)
178.85 %
Price targets and forecasts for Estia Health are not yet available.

Estia Health Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
2/19/20240.09AUD449.45 MAUD2024 Q2
8/20/20230.05AUD365.40 MAUD2023 Q4
2/20/20230.07AUD365.40 MAUD2023 Q2
8/23/2022-0.01AUD346.62 MAUD2022 Q4
2/22/20220.03AUD349.16 MAUD2022 Q2
2/23/20210.03AUD347.13 MAUD2021 Q2
8/18/20200.06AUD345.10 MAUD2020 Q4
2/25/20200.05AUD328.86 MAUD2020 Q2
8/20/20190.06AUD-AUD2019 Q4
2/26/20190.08AUD-AUD2019 Q2

EESG©

Eulerpool ESG Scorecard© for the Estia Health stock

84/100
77
Environment
99
Social
77
Governance
E

Environment

20
Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions24,989
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Estia Health shareholder structure

% Name
6.50740%
Milford Asset Management Ltd.
Milford Asset Management Ltd.
5.90898%
DWS Investment GmbH
DWS Investment GmbH
4.98583%
Perpetual Investment Management Limited
Perpetual Investment Management Limited
4.35086%
Wilson Asset Management (International) Pty. Ltd.
Wilson Asset Management (International) Pty. Ltd.
4.31278%
Argo Investments Limited
Argo Investments Limited
3.65150%
Mitsubishi UFJ Financial Group Inc
Mitsubishi UFJ Financial Group Inc

Estia Health Executives and Management Board

IT

Mr. Ian Thorley

Chief Executive Officer, Managing Director, Executive Director · since 2016

Compensation917,618.00 AUD
SL

Mr. Steve Lemlin

Chief Financial Officer

Compensation731,606.00 AUD
SB

Mr. Sean Bilton

Deputy Chief Executive Officer, Chief Operating Officer

Compensation639,844.00 AUD
GW

Dr. Gary Weiss

(68)

Non-Executive Independent Chairman of the Board

Compensation280,000.00 AUD
PF

Mr. Paul Foster

Non-Executive Independent Director

Compensation135,000.00 AUD

Estia Health Supply Chain

Estia Health Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
4 companies
#Name1M3M6M1Y2YTrend
1
0.52
0.28
-0.29
-0.10
0.83
2
Citigroup
Supplier
0.20
0.01
-0.51
0.14
0.77
3
0.41
-0.03
-0.03
-0.24
0.65
4
0.54
0.28
-0.16
0.03
0.42

Frequently asked questions about Estia Health

Estia Health Ltd is a leading provider of aged care in Australia. Their business model revolves around offering a range of residential care services for the elderly. Their facilities provide personalized care and support for seniors, ensuring their physical, emotional, and social well-being. Estia Health focuses on creating a comfortable and safe environment for residents and delivering high-quality care services. With a strong commitment to excellence, Estia Health Ltd aims to enhance the quality of life for seniors by providing comprehensive care solutions tailored to individual needs.

All fundamentals and in-depth analysis of Estia Health

Our stock analysis for Estia Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Estia Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.